// App-Quantinova.ai

: Late Breaking Abstract - Reduction of COPD exacerbations with extrafine single inhaler triple therapy: post-hoc analysis by exacerbation treatment of the TRIBUTE study

Researchers

Presenter

  • Leonardo Fabbri

Principal Investigators

  • Dave Singh

  • Ilaria Valente

  • Alessandro Guasconi

  • Helene Prunier

  • George Georges

  • Alberto Papi

Medical Centers

  • University of Ferrara, Ferrara, Italy

  • University of Manchester, Manchester, United Kingdom

  • Chiesi Farmaceutici, S.p.A, Parma, Italy,

  • Chiesi Farmaceutici Inc., Cary, United States of America

Locations

  • Italy

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved